Skip to main content
. Author manuscript; available in PMC: 2009 Oct 4.
Published in final edited form as: Mol Genet Metab. 2005 Dec 13;88(1):78–85. doi: 10.1016/j.ymgme.2005.10.008

Fig. 3.

Fig. 3

Degree of hypertrophy (A), degree of left ventricular outflow tract obstruction (B), and age at diagnosis (C) for genotyped subjects. Genotyped patients with hypertrophic cardiomyopathy are grouped on the X-axis as hosting as hosting no putative mutation (genotype negative), hosting a myofilament mutation (myofilament-HCM), a MLP-mutation or a TCAP-mutation. Unless otherwise noted, all pair wise comparisons are not statistically significant. *p < 0.05 compared to all other groups.